@PathDocBoston@MGHPathology@mlage I wonder if this individual will find after residency that he or she quite misses the instant gratification of cutting into a specimen and making gross findings! Or the satisfaction of making the dx on gross alone (still an occasional opportunity on frozen section).
@dychiang8 Virginia. I was biking with my friends from Chapel Hill up to Washington DC, an adventure that I also wonder if three black young men would have taken with such certainty of their safety along the way. Well, I don't have to wonder, really.
As a college student, I was exploring a construction site, but was arrested at gun point, charged with trespass, and released
Now, suppose I had been a young black man. Consider: 1) Would I now be a practicing MD at a major university? 2) would I be alive? I am haunted by this
After my lecture about the racist exploitation of Henrietta Lacks, a white man claiming to be a retired doctor from Johns Hopkins proclaimed I was wrong because “patients in the colored ward got BETTER care because we tested experimental treatments on them.” 😳#BlackintheIvory
@SciGuySpace Hmm... sounds like a really straight forward way to boost up the funding reserves up for the Europa Clipper mission. But they don't need funding reserves, do they?
@kmelville91 @Clive_G_Brown @nanopore I am thrilled to see what @nanopore can do with the power of the flongle! Fusion detection is THE low hanging fruit for the nanopore in the clinic. 100% concordance with that other sequencing system, but zero capital cost, and blindingly fast. A no brainer.
One step closer to ultrarapid, @nanopore based fusion detection. Further optimization of enrichment levels might be needed, but this is getting very close! https://t.co/xdcZB9flPw
Our article on @nanopore sequencing for clinical fusion oncogene detection is now out in @JMDiagn. With the $100 'flongle' flow cell, this could be a killer ap for nanopore sequencing in clinical labs: https://t.co/Vurp7yIKqP
Great read from a former UNC MSTP, now JHU oncology fellow. Isaac is right on when he says: "end-of-life care is not checklist medicine"
Opinion | My patients are dying. But it’s their right to keep going. https://t.co/QyL0CKjsz2
I live in a border state. I appreciate the need to enforce and protect our international boundaries, but this zero-tolerance policy is cruel. It is immoral. And it breaks my heart.
https://t.co/he1uw1E96A
After 6 months of listening & learning from people across the cancer community, I highlighted some key areas of focus for #NCIFuture at #AACR18 this week. If you missed it, be sure to check out my blog post: https://t.co/UdDARTOC7c